The landscape of dementia diagnosis has evolved drastically with the arrival of refined biomarkers, which includes amyloid PET scans, tau imaging, and blood-primarily based tests that can detect Alzheimer's pathology decades in advance of indicators emerge. While these technological innovations depict exceptional development in knowledge neurodegenerative conditions, they've not dimin... https://cyrili319hqz7.wikicommunications.com/user